Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacibekitug in Systemic Lupus Erythematosus (BUTTERFLY)
NCT01405196Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2011
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of pacibekitug in systemic lupus erythematosus (SLE), sponsored by Pfizer. Started Dec 2011; status: completed.
02
Drugs
pacibekitug
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01405196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405196.